Improving Access to Healthcare
Improving Access to Healthcare
Each day, Sanofi’s 110,000 employees seek to preserve the health of people all over the world and improve access to care. Working with our partners, we have the resources and the expertise to meet this challenge.
- Access to Care: Access to quality healthcare is the true challenge. Improving care infrastructures and policies, implementing differentiated pricing programs, and contributing to local economic development are some of the areas where we make a difference each day. Read more…
- Innovation for Patients: Innovation is both a mindset and a goal shared by everyone at Sanofi. Our ongoing commitment drives the development of innovative products and services adapted to the needs of patients and communities. Read more…
- Patient Safety: Ensuring the safety and quality of our products is one of Sanofi’s key priorities. Insofar as possible, we seek to manage the risks associated with the use of our products. Read more…
Videos From This Campaign
FMRs from this campaign
Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection
Bridgewater, NJ, December 8, 2014 /3BL Media/ - Sanofi announced that following a priority review, the U.S. Food and Drug Administration has approved Priftin® (rifapentine) in combination with isoniazid (INH) for a new indication for the treatment of latent tuberculosis infection (LTBI) in patients two years of age and older...
Dec 8, 2014 11:30 AM ET
Sanofi Addresses Healthcare Disparities During Minority Health Awareness Month
Sanofi’s Diversity Employee Resource Group, ADVANCE (Alliance for DiVersificAtion, iNClusion, and Enrichment) celebrated its 1st Anniversary, on April 22, 2014, and closed out “Minority Health Awareness Month,” by hosting an expert speaker panel during a program...
May 16, 2014 9:00 AM ET
Every Child, In Every Neighborhood, Deserves a Doctor
Recently I met Isani Castro, a young woman who has been a patient of Children’s Health Fund’s (CHF) New York project since she was five years old. When she first came to CHF, Isani had a serious eye problem that affected her ability to learn and thrive. Thankfully, a CHF mobile medical clinic drove into her New York...
Apr 4, 2014 3:00 PM ET
Merial Announces EU Approval For NexGard®
February 19, 2014 /3BL Media/ - Sanofi and its animal health division, Merial, today announced that the European Commission has approved NexGard® (afoxolaner) for the treatment of flea and tick infestations in dogs. One oral treatment kills fleas for at least 5 weeks and ticks for up to one month. NexGard can also be used as part of a treatment strategy for the control of...
Feb 20, 2014 9:00 AM ET
Sanofi Patient Connection™...A Look Back at the First Year
April 26, 2013 /3BL Media/ - In 2012 Sanofi US launched “Sanofi Patient Connection (SPC)” a cutting-edge program to provide reimbursement support and patient assistance to help patients access our products, additional services and resources that may be useful in the comprehensive management of their diseases. Let’s take a look back at the first year to see how the program is...
Apr 26, 2013 9:00 AM ET
More From Sanofi
Wednesday, April 22, 2015 - 3:30pm
Wednesday, April 15, 2015 - 8:35am
Monday, April 13, 2015 - 12:00pm